Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
rubber dildos.
Popular Articles

Benefit To Women Not Enough To Sway Men To Get HPV Vaccine
Informing men that a new vaccine to prevent human papillomavirus (HPV) would also help protect their female partners against developing cervical cancer from the sexually transmitted infection did not increase their interest in getting the vaccine, according to a new Florida State University study.
diet pills
Global Confirmed Swine Flu Cases Nears 10,000
According to WHO (World Health Organization), the total number of confirmed swine flu A(H1N1) cases of human infections stands at 9,830, including 79 deaths. The numbers of confirmed cases are rising by approximately 1,000 per day, says WHO. Japan has seen confirmed cases rise sharply over the last few days.
News of the day
Victorian Invention A Watchful Approach To Parkinson's
Victorian researchers have developed a wristwatch that continuously monitors the health status of people with Parkinson"s disease to help doctors manage their treatment, Victorian Minister for Innovation Gavin Jennings said today.
Diagnostics

Indian Authorities Asked To Stop Licensing Artemisinin-Only Malaria Drugs

The Drugs Controller General of India (DCGI) asked state drug licensing authorities to avoid authorizing new licenses for single drug formulations of artemisinin and withdraw existing licences for these types of drugs by the end of this month, livemint.com reports. To prevent drug resistance, the WHO has advised against the use of drugs that only contain artemisinin to treat malaria and recommends using artemsinin in combination with other drugs. "India"s drug advisory body, the drug consultative committee, had in December approved the phasing out of the [artemisinin only] drug[s] from the market," livemint.com writes. H.G. Koshia, the commissioner of the food and drug control administration for the state of Gujarat, said, "The state department has received the last directive in this regard a couple of weeks ago, and we have already informed all existing licence holders to stop manufacturing. The brand recalls from the market is also in progress, though there aren"t many at present." According to livemint.com: "Ipca Laboratories Ltd., Themis Medicare Ltd., Plethico Pharmaceuticals Ltd., GVS Laboratories Ltd., Cipla and Lupin Ltd. are some of the top firms in the domestic anti-malaria market. These are also key suppliers to overseas markets through [the] WHO or direct channels, and most have already stopped making the product following [the] WHO"s warning on single oral therapy using artemisinin and its derivatives." R.B. Smartha, the managing director of Mumbai-based Interlink Marketing Consultancy Pvt. Ltd., said, "The impact of the DCGI order would not be big for the industry as the market for oral single formulation of artemisinin derivatives has already shrunk" (Pandeya/Unnikrishnan, 7/22). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009